Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-05-03

Clinical Trial Update: Articaine 4% Versus Lidocaine 2% for Local Anesthesia of MIH-affected Maxillary Molars [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial comparing articaine 4% to lidocaine 2% for local anesthesia in Molar Incisor Hypomineralisation-affected maxillary molars has completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Articaine (4%) (articaine)
  • Lidocaine 2% (Lidocaine)

Snippet

Sponsor: Tishreen University | Conditions: Molar Incisor Hypomineralisation | Phase 1, Phase 2 | Status: COMPLETED